In-depth characterization of the secretome of colorectal cancer metastatic cells identifies key proteins in cell adhesion, migration, and invasion

Molecular and Cellular Proteomics

Volumn 12, Issue 6, 2013, Pages 1602-1620

  Barderas, Rodrigo ^a,d   Mendes, Marta ^a   Torres, Sofia ^a   Bartolomé, Rubén A ^a   López Lucendog, María ^a   Villar Vázquez, Roi ^a   Peláez García, Alberto ^a   Fuente, Eduardo ^b   Bonilla, Félix ^c   Casal, J Ignacio ^a  

^a CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

^b HOSPITAL DE CABUEÑES   (Spain)

^c HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^d UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE RIBOSYLATION FACTOR 6; ADENYLATE KINASE; ADENYLATE KINASE 1; CALGRANULIN A; CALGRANULIN B; CATHEPSIN S; CD59 ANTIGEN; CELL PROTEIN; ENDOTHELIAL PROTEIN C RECEPTOR; FASCIN; GLUCOSE REGULATED PROTEIN; GROWTH DIFFERENTIATION FACTOR 15; HYDROXYMETHYLGLUTARYL COENZYME A SYNTHASE; MIDKINE; NEPHRONECTIN; PODOCALYXIN; PODOCALYXIN LIKE PROTEIN 1; PROHIBITIN; PROHIBITIN 2; SCLEROSTIN; SELENIUM BINDING PROTEIN; SELENIUM BINDING PROTEIN 1; SMALL INTERFERING RNA; SYNAPTOGYRIN; SYNAPTOGYRIN 2; TAX1 BINDING PROTEIN 3; TETRASPANIN; TETRASPANIN 8; UNCLASSIFIED DRUG; ZYMOGEN GRANULE; ZYMOGEN GRANULE PROTEIN 16;

AMINO ACID SEQUENCE; ARTICLE; CANCER CELL; CELL ADHESION; CELL INVASION; CELL MIGRATION; COLORECTAL CANCER; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN DETERMINATION; TANDEM MASS SPECTROMETRY; TUMOR INVASION; UNINDEXED SEQUENCE; UPREGULATION;

CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; COLON; COLONIC NEOPLASMS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; ISOTOPE LABELING; LIVER; LIVER NEOPLASMS; MALE; MASS SPECTROMETRY; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; PROGNOSIS; PROTEIN INTERACTION MAPPING; PROTEOME; RNA, SMALL INTERFERING; TUMOR MARKERS, BIOLOGICAL;

EID: 84878724168     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M112.022848     Document Type: Article

References (86)

1. Locker, G. Y., Hamilton, S., Harris, J., Jessup, J. M., Kemeny, N., Macdonald, J. S., Somerfield, M. R., Hayes, D. F., and Bast, R. C., Jr. (2006) ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J. Clin. Oncol. 24, 5313-5327 (Pubitemid 46631379)
2. Duffy, M. J., van Dalen, A., Haglund, C., Hansson, L., Holinski-Feder, E., Klapdor, R., Lamerz, R., Peltomaki, P., Sturgeon, C., and Topolcan, O. (2007) Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use. Eur. J. Cancer 43, 1348-1360 (Pubitemid 46874070)
3. Babel, I., Barderas, R., Díaz-Uriarte, R., Martínez- Torrecuadrada, J. L., Sánchez-Carbayo, M., and Casal, J. I. (2009) Identification of tumorassociated autoantigens for the diagnosis of colorectal cancer in serum using high density protein microarrays. Mol. Cell. Proteomics 8, 2382-2395
4. Babel, I., Barderas, R., Diaz-Uriarte, R., Moreno, V., Suarez, A., Fernandez- Acenero, M. J., Salazar, R., Capella, G., and Casal, J. I. (2011) Identification of MST1/STK4 and SULF1 proteins as autoantibody targets for the diagnosis of colorectal cancer by using phage microarrays. Mol. Cell. Proteomics 10, M110.001784
5. Hundt, S., Haug, U., and Brenner, H. (2007) Blood markers for early detection of colorectal cancer: a systematic review. Cancer Epidemiol. Biomarkers Prev. 16, 1935-1953 (Pubitemid 47621167)
6. Barderas, R., Babel, I., Díaz-Uriarte, R., Moreno, V., Suárez, A., Bonilla, F., Villar-Vázquez, R., Capellá, G., and Casal, J. I. (2012) An optimized predictor panel for colorectal cancer diagnosis based on the combination of tumor-associated antigens obtained from protein and phage microarrays. J. Proteomics 75, 4647-4655
7. Smith, J. J., Deane, N. G., Dhawan, P., and Beauchamp, R. D. (2008) Regulation of metastasis in colorectal adenocarcinoma: a collision between development and tumor biology. Surgery 144, 353-366
8. Weitz, J., Koch, M., Debus, J., Höhler, T., Galle, P. R., and Büchler, M. W. (2005) Colorectal cancer. Lancet 365, 153-165 (Pubitemid 40091806)
9. Fearon, E. R. (2011) Molecular genetics of colorectal cancer. Annu. Rev. Pathol. 6, 479-507
10. Nguyen, D. X., and Massagué, J. (2007) Genetic determinants of cancer metastasis. Nat. Rev. Genet. 8, 341-352 (Pubitemid 46625811)
11. Hanash, S. M., Pitteri, S. J., and Faca, V. M. (2008) Mining the plasma proteome for cancer biomarkers. Nature 452, 571-579 (Pubitemid 351483371)
12. Hudson, M. E., Pozdnyakova, I., Haines, K., Mor, G., and Snyder, M. (2007) Identification of differentially expressed proteins in ovarian cancer using high-density protein microarrays. Proc. Natl. Acad. Sci. U.S.A. 104, 17494-17499 (Pubitemid 350219866)
13. Hanash, S., and Taguchi, A. (2010) The grand challenge to decipher the cancer proteome. Nat. Rev. Cancer 10, 652-660
14. Morikawa, K., Walker, S. M., Nakajima, M., Pathak, S., Jessup, J. M., and Fidler, I. J. (1988) Influence of organ environment on the growth, selection, and metastasis of human colon carcinoma cells in nude mice. Cancer Res. 48, 6863-6871 (Pubitemid 19012219)
15. Morikawa, K., Walker, S. M., Jessup, J. M., and Fidler, I. J. (1988) In vivo selection of highly metastatic cells from surgical specimens of different primary human colon carcinomas implanted into nude mice. Cancer Res. 48, 1943-1948
16. Kuniyasu, H., Ohmori, H., Sasaki, T., Sasahira, T., Yoshida, K., Kitadai, Y., and Fidler, I. J. (2003) Production of interleukin 15 by human colon cancer cells is associated with induction of mucosal hyperplasia, angiogenesis, and metastasis. Clin. Cancer Res. 9, 4802-4810 (Pubitemid 37323283)
17. Luque-García, J. L., Martínez-Torrecuadrada, J. L., Epifano, C., Cañamero, M., Babel, I., and Casal, J. I. (2010) Differential protein expression on the cell surface of colorectal cancer cells associated with tumor metastasis. Proteomics 10, 940-952
18. Li, A., Varney, M. L., and Singh, R. K. (2004) Constitutive expression of growth regulated oncogene (gro) in human colon carcinoma cells with different metastatic potential and its role in regulating their metastatic phenotype. Clin. Exp. Metastasis 21, 571-579 (Pubitemid 40298656)
19. Calon, A., Espinet, E., Palomo-Ponce, S., Tauriello, D. V., Iglesias, M., Céspedes, M. V., Sevillano, M., Nadal, C., Jung, P., Zhang, X. H., Byrom, D., Riera, A., Rossell, D., Mangues, R., Massagué, J., Sancho, E., and Batlle, E. (2012) Dependency of colorectal cancer on a TGF-β-driven program in stromal cells for metastasis initiation. Cancer Cell 22, 571-584
20. Barderas, R., Bartolomé, R. A., Fernandez-Aceñero, M. J., Torres, S., and Casal, J. I. (2012) High expression of IL-13 receptor α2 in colorectal cancer is associated with invasion, liver metastasis, and poor prognosis. Cancer Res. 72, 2780-2790
21. Hegde, P., Qi, R., Gaspard, R., Abernathy, K., Dharap, S., Earle-Hughes, J., Gay, C., Nwokekeh, N. U., Chen, T., Saeed, A. I., Sharov, V., Lee, N. H., Yeatman, T. J., and Quackenbush, J. (2001) Identification of tumor markers in models of human colorectal cancer using a 19,200-element complementary DNA microarray. Cancer Res. 61, 7792-7797 (Pubitemid 33049366)
22. Ghosh, D., Yu, H., Tan, X. F., Lim, T. K., Zubaidah, R. M., Tan, H. T., Chung, M. C., and Lin, Q. (2011) Identification of key players for colorectal cancer metastasis by iTRAQ quantitative proteomics profiling of isogenic SW480 and SW620 cell lines. J. Proteome Res. 10, 4373-4387
23. Xue, H., Lü, B., Zhang, J., Wu, M., Huang, Q., Wu, Q., Sheng, H., Wu, D., Hu, J., and Lai, M. (2010) Identification of serum biomarkers for colorectal cancer metastasis using a differential secretome approach. J. Proteome Res. 9, 545-555
24. Leibovitz, A., Stinson, J. C., McCombs, W. B., 3rd, McCoy, C. E., Mazur, K. C., and Mabry, N. D. (1976) Classification of human colorectal adenocarcinoma cell lines. Cancer Res. 36, 4562-4569
25. Geiger, T., Wisniewski, J. R., Cox, J., Zanivan, S., Kruger, M., Ishihama, Y., and Mann, M. (2011) Use of stable isotope labeling by amino acids in cell culture as a spike-in standard in quantitative proteomics. Nat. Protoc. 6, 147-157
26. Wessel, D., and Flügge, U. I. (1984) A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids. Anal. Biochem. 138, 141-143 (Pubitemid 14146660)
27. Wiśniewski, J. R., Zougman, A., Nagaraj, N., and Mann, M. (2009) Universal sample preparation method for proteome analysis. Nat. Methods 6, 359-362
28. Käll, L., Canterbury, J. D., Weston, J., Noble, W. S., and MacCoss, M. J. (2007) Semi-supervised learning for peptide identification from shotgun proteomics datasets. Nat. Methods 4, 923-925 (Pubitemid 350042380)
29. Bendtsen, J. D., Jensen, L. J., Blom, N., Von Heijne, G., and Brunak, S. (2004) Feature-based prediction of non-classical and leaderless protein secretion. Protein Eng. Des. Sel. 17, 349-356 (Pubitemid 39093515)
30. Mathivanan, S., Fahner, C. J., Reid, G. E., and Simpson, R. J. (2012) ExoCarta 2012: database of exosomal proteins, RNA, and lipids. Nucleic Acids Res. 40, D1241-D1244
31. Jensen, L. J., Kuhn, M., Stark, M., Chaffron, S., Creevey, C., Muller, J., Doerks, T., Julien, P., Roth, A., Simonovic, M., Bork, P., and von Mering, C. (2009) STRING 8-a global view on proteins and their functional interactions in 630 organisms. Nucleic Acids Res. 37, D412-D416
32. Szklarczyk, D., Franceschini, A., Kuhn, M., Simonovic, M., Roth, A., Minguez, P., Doerks, T., Stark, M., Muller, J., Bork, P., Jensen, L. J., and von Mering, C. (2011) The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res. 39, D561-D568
33. Cerami, E., Gao, J., Dogrusoz, U., Gross, B. E., Sumer, S. O., Aksoy, B. A., Jacobsen, A., Byrne, C. J., Heuer, M. L., Larsson, E., Antipin, Y., Reva, B., Goldberg, A. P., Sander, C., and Schultz, N. (2012) The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2, 401-404
34. Yang, W., Cai, Q., Lui, V. W., Everley, P. A., Kim, J., Bhola, N., Quesnelle, K. M., Zetter, B. R., Steen, H., Freeman, M. R., and Grandis, J. R. (2010) Quantitative proteomics analysis reveals molecular networks regulated by epidermal growth factor receptor level in head and neck cancer. J. Proteome Res. 9, 3073-3082
35. Sherr, C. J. (2006) Autophagy by ARF: a short story. Mol. Cell 22, 436-437
36. Koopmann, J., Rosenzweig, C. N., Zhang, Z., Canto, M. I., Brown, D. A., Hunter, M., Yeo, C., Chan, D. W., Breit, S. N., and Goggins, M. (2006) Serum markers in patients with resectable pancreatic adenocarcinoma: macrophage inhibitory cytokine 1 versus CA19-9. Clin. Cancer Res. 12, 442-446 (Pubitemid 43166133)
37. Welsh, J. B., Sapinoso, L. M., Kern, S. G., Brown, D. A., Liu, T., Bauskin, A. R., Ward, R. L., Hawkins, N. J., Quinn, D. I., Russell, P. J., Sutherland, R. L., Breit, S. N., Moskaluk, C. A., Frierson, H. F., Jr., and Hampton, G. M. (2003) Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum. Proc. Natl. Acad. Sci. U.S.A. 100, 3410-3415 (Pubitemid 36356597)
38. Makawita, S., Smith, C., Batruch, I., Zheng, Y., Ruckert, F., Grutzmann, R., Pilarsky, C., Gallinger, S., and Diamandis, E. P. (2011) Integrated proteomic profiling of cell line conditioned media and pancreatic juice for the identification of pancreatic cancer biomarkers. Mol. Cell. Proteomics 10, M111.008599
39. Sardana, G., Jung, K., Stephan, C., and Diamandis, E. P. (2008) Proteomic analysis of conditioned media from the PC3, LNCaP, and 22Rv1 prostate cancer cell lines: discovery and validation of candidate prostate cancer biomarkers. J. Proteome Res. 7, 3329-3338
40. Psaila, B., and Lyden, D. (2009) The metastatic niche: adapting the foreign soil. Nat. Rev. Cancer 9, 285-293
41. Ratajczak, J., Wysoczynski, M., Hayek, F., Janowska-Wieczorek, A., and Ratajczak, M. Z. (2006) Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia 20, 1487-1495 (Pubitemid 44264090)
42. Lee, T. H., D'Asti, E., Magnus, N., Al-Nedawi, K., Meehan, B., and Rak, J. (2011) Microvesicles as mediators of intercellular communication in cancer-the emerging science of cellular 'debris. ' Semin. Immunopathol. 33, 455-467
43. Muralidharan-Chari, V., Clancy, J. W., Sedgwick, A., and D'Souza-Schorey, C. (2010) Microvesicles: mediators of extracellular communication during cancer progression. J. Cell Sci. 123, 1603-1611
44. Peinado, H., Rafii, S., and Lyden, D. (2008) Inflammation joins the "niche." Cancer Cell 14, 347-349
45. Hiratsuka, S., Nakamura, K., Iwai, S., Murakami, M., Itoh, T., Kijima, H., Shipley, J. M., Senior, R. M., and Shibuya, M. (2002) MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis. Cancer Cell 2, 289-300 (Pubitemid 41043963)
46. Kim, H. J., Kang, H. J., Lee, H., Lee, S. T., Yu, M. H., Kim, H., and Lee, C. (2009) Identification of S100A8 and S100A9 as serological markers for colorectal cancer. J. Proteome Res. 8, 1368-1379
47. Rodríguez-González, R., Millán, M., Sobrino, T., Miranda, E., Brea, D., de la Ossa, N. P., Blanco, M., Perez, J., Dorado, L., Castellanos, M., Lomas, D. A., Moro, M. A., Dávalos, A., and Castillo, J. (2011) The natural tissue plasminogen activator inhibitor neuroserpin and acute ischaemic stroke outcome. Thromb. Haemost. 105, 421-429
48. Larrucea, S., Butta, N., Arias-Salgado, E. G., Alonso-Martin, S., Ayuso, M. S., and Parrilla, R. (2008) Expression of podocalyxin enhances the adherence, migration, and intercellular communication of cells. Exp. Cell Res. 314, 2004-2015
49. Larsson, A., Johansson, M. E., Wangefjord, S., Gaber, A., Nodin, B., Kucharzewska, P., Welinder, C., Belting, M., Eberhard, J., Johnsson, A., Uhlén, M., and Jirström, K. (2011) Overexpression of podocalyxin-like protein is an independent factor of poor prognosis in colorectal cancer. Br. J. Cancer 105, 666-672
50. Meng, X., Ezzati, P., and Wilkins, J. A. (2011) Requirement of podocalyxin in TGF-β induced epithelial mesenchymal transition. PLoS One 6, e18715
51. Wilson, N. H., and Key, B. (2007) Neogenin: one receptor, many functions. Int. J. Biochem. Cell Biol. 39, 874-878 (Pubitemid 46575319)
52. Martín, M., Simon-Assmann, P., Kedinger, M., Martin, M., Mangeat, P., Real, F. X., and Fabre, M. (2006) DCC regulates cell adhesion in human colon cancer derived HT-29 cells and associates with ezrin. Eur. J. Cell Biol. 85, 769-783 (Pubitemid 44070577)
53. Burden, R. E., Gormley, J. A., Jaquin, T. J., Small, D. M., Quinn, D. J., Hegarty, S. M., Ward, C., Walker, B., Johnston, J. A., Olwill, S. A., and Scott, C. J. (2009) Antibody-mediated inhibition of cathepsin S blocks colorectal tumor invasion and angiogenesis. Clin. Cancer Res. 15, 6042-6051
54. Yang, Y., Yixuan, Y., Lim, S. K., Kiat, L. S., Choong, L. Y., Yee, C. L., Lee, H., Huiyin, L., Chen, Y., Yunhao, C., Chong, P. K., Kuan, C. P., Ashktorab, H., Hassan, A., Wang, T. T., Ting, W. T., Salto-Tellez, M., Manuel, S. T., Yeoh, K. G., Guan, Y. K., Lim, Y. P., and Pin, L. Y. (2010) Cathepsin S mediates gastric cancer cell migration and invasion via a putative network of metastasis-associated proteins. J. Proteome Res. 9, 4767-4778
55. Schick, C., Pemberton, P. A., Shi, G. P., Kamachi, Y., Cataltepe, S., Bartuski, A. J., Gornstein, E. R., Brömme, D., Chapman, H. A., and Silverman, G. A. (1998) Cross-class inhibition of the cysteine proteinases cathepsins K, L, and S by the serpin squamous cell carcinoma antigen 1: a kinetic analysis. Biochemistry 37, 5258-5266 (Pubitemid 28176527)
56. Yasuda, S., Morokawa, N., Wong, G. W., Rossi, A., Madhusudhan, M. S., Sali, A., Askew, Y. S., Adachi, R., Silverman, G. A., Krilis, S. A., and Stevens, R. L. (2005) Urokinase-type plasminogen activator is a preferred substrate of the human epithelium serine protease tryptase epsilon/ PRSS22. Blood 105, 3893-3901 (Pubitemid 40656134)
57. Hastings, G. A., Coleman, T. A., Haudenschild, C. C., Stefansson, S., Smith, E. P., Barthlow, R., Cherry, S., Sandkvist, M., and Lawrence, D. A. (1997) Neuroserpin, a brain-associated inhibitor of tissue plasminogen activator is localized primarily in neurons. Implications for the regulation of motor learning and neuronal survival. J. Biol. Chem. 272, 33062-33067 (Pubitemid 28023647)
58. Ye, C., Qi, M., Fan, Q. W., Ito, K., Akiyama, S., Kasai, Y., Matsuyama, M., Muramatsu, T., and Kadomatsu, K. (1999) Expression of midkine in the early stage of carcinogenesis in human colorectal cancer. Br. J. Cancer 79, 179-184 (Pubitemid 28566945)
59. Colombo, C., Creighton, C. J., Ghadimi, M. P., Bolshakov, S., Warneke, C. L., Zhang, Y., Lusby, K., Zhu, S., Lazar, A. J., West, R. B., van de Rijn, M., and Lev, D. (2011) Increased midkine expression correlates with desmoid tumour recurrence: a potential biomarker and therapeutic target. J. Pathol. 225, 574-582
60. Muramatsu, H., Zou, P., Suzuki, H., Oda, Y., Chen, G. Y., Sakaguchi, N., Sakuma, S., Maeda, N., Noda, M., Takada, Y., and Muramatsu, T. (2004) α4β1- and α6β1-integrins are functional receptors for midkine, a heparin- binding growth factor. J. Cell Sci. 117, 5405-5415
61. Kim, D. K., Lee, S. C., and Lee, H. W. (2009) CD137 ligand-mediated reverse signals increase cell viability and cytokine expression in murine myeloid cells: involvement of mTOR/p70S6 kinase and Akt. Eur. J. Immunol. 39, 2617-2628
62. Dimberg, J., Hugander, A., and Wågsäter, D. (2006) Expression of CD137 and CD137 ligand in colorectal cancer patients. Oncol. Rep. 15, 1197-1200
63. Kim, S. A., Lee, Y., Jung, D. E., Park, K. H., Park, J. Y., Gang, J., Jeon, S. B., Park, E. C., Kim, Y. G., Lee, B., Liu, Q., Zeng, W., Yeramilli, S., Lee, S., Koh, S. S., and Song, S. Y. (2009) Pancreatic adenocarcinoma upregulated factor (PAUF), a novel up-regulated secretory protein in pancreatic ductal adenocarcinoma. Cancer Sci. 100, 828-836
64. Park, H. D., Lee, Y., Oh, Y. K., Jung, J. G., Park, Y. W., Myung, K., Kim, K. H., Koh, S. S., and Lim, D. S. (2011) Pancreatic adenocarcinoma up-regulated factor promotes metastasis by regulating TLR/CXCR4 activation. Oncogene 30, 201-211
65. Sotsios, Y., Whittaker, G. C., Westwick, J., and Ward, S. G. (1999) The CXC chemokine stromal cell-derived factor activates a Gi-coupled phosphoinositide 3-kinase in T lymphocytes. J. Immunol. 163, 5954-5963
66. Kim, S. J., Lee, Y., Kim, N. Y., Hwang, Y., Hwang, B., Min, J. K., and Koh, S. S. (2012) Pancreatic adenocarcinoma up-regulated factor, a novel endothelial activator, promotes angiogenesis and vascular permeability. Oncogene doi: 10.1038/onc.2012.366
67. Kang, Y. J., Kim, S. O., Shimada, S., Otsuka, M., Seit-Nebi, A., Kwon, B. S., Watts, T. H., and Han, J. (2007) Cell surface 4-1BBL mediates sequential signaling pathways 'downstream' of TLR and is required for sustained TNF production in macrophages. Nat. Immunol. 8, 601-609 (Pubitemid 46785124)
68. Levi, A., Eldridge, J. D., and Paterson, B. M. (1985) Molecular cloning of a gene sequence regulated by nerve growth factor. Science 229, 393-395 (Pubitemid 15073084)
69. Yanagita, M., Oka, M., Watabe, T., Iguchi, H., Niida, A., Takahashi, S., Akiyama, T., Miyazono, K., Yanagisawa, M., and Sakurai, T. (2004) USAG-1: a bone morphogenetic protein antagonist abundantly expressed in the kidney. Biochem. Biophys. Res. Commun. 316, 490-500 (Pubitemid 38338618)
70. Blish, K. R., Wang, W., Willingham, M. C., Du, W., Birse, C. E., Krishnan, S. R., Brown, J. C., Hawkins, G. A., Garvin, A. J., D'Agostino, R. B., Jr., Torti, F. M., and Torti, S. V. (2008) A human bone morphogenetic protein antagonist is down-regulated in renal cancer. Mol. Biol. Cell 19, 457-464 (Pubitemid 351272135)
71. Pasquale, E. B. (2010) Eph receptors and ephrins in cancer: bidirectional signalling and beyond. Nat. Rev. Cancer 10, 165-180
72. Wong, E. V., Kerner, J. A., and Jay, D. G. (2004) Convergent and divergent signaling mechanisms of growth cone collapse by ephrinA5 and slit2. J. Neurobiol. 59, 66-81 (Pubitemid 38391809)
73. Minami, M., Koyama, T., Wakayama, Y., Fukuhara, S., and Mochizuki, N. (2011) EphrinA/EphA signal facilitates insulin-like growth factor-I-induced myogenic differentiation through suppression of the Ras/extracellular signal-regulated kinase 1/2 cascade in myoblast cell lines. Mol. Biol. Cell 22, 3508-3519
74. Bourgin, C., Murai, K. K., Richter, M., and Pasquale, E. B. (2007) The EphA4 receptor regulates dendritic spine remodeling by affecting β1-integrin signaling pathways. J. Cell Biol. 178, 1295-1307 (Pubitemid 47480233)
75. Pasquale, E. B. (1997) The Eph family of receptors. Curr. Opin. Cell Biol. 9, 608-615 (Pubitemid 27424916)
76. Chen, H. T., Tsou, H. K., Chang, C. H., and Tang, C. H. (2012) Hepatocyte growth factor increases osteopontin expression in human osteoblasts through PI3K, Akt, c-Src, and AP-1 signaling pathway. PLoS One 7, e38378
77. Naci, D., El Azreq, M. A., Chetoui, N., Lauden, L., Sigaux, F., Charron, D., Al-Daccak, R., and Aoudjit, F. (2012) α2β integrin promotes chemoresistance against doxorubicin in cancer cells through extracellular signal- regulated kinase (ERK). J. Biol. Chem. 287, 17065-17076
78. Liebmann, C. (2001) Bradykinin signalling to MAP kinase: cell-specific connections versus principle mitogenic pathways. Biol. Chem. 382, 49-55
79. Kim, H. K., Oh, D. S., Lee, S. B., Ha, J. M., and Joe, Y. A. (2008) Antimigratory effect of TK1-2 is mediated in part by interfering with integrin α2β1. Mol. Cancer Ther. 7, 2133-2141
80. Nikolopoulos, S. N., and Giancotti, F. G. (2005) Netrin-integrin signaling in epithelial morphogenesis, axon guidance and vascular patterning. Cell Cycle 4, e131-135 (Pubitemid 41359711)
81. Endo, M., and Yamashita, T. (2009) Inactivation of Ras by p120GAP via focal adhesion kinase dephosphorylation mediates RGMa-induced growth cone collapse. J. Neurosci. 29, 6649-6662
82. Yanagita, M. (2005) BMP antagonists: their roles in development and involvement in pathophysiology. Cytokine Growth Factor Rev. 16, 309-317 (Pubitemid 40910320)
83. Shon, S. K., Kim, A., Kim, J. Y., Kim, K. I., Yang, Y., and Lim, J. S. (2009) Bone morphogenetic protein-4 induced by NDRG2 expression inhibits MMP-9 activity in breast cancer cells. Biochem. Biophys. Res. Commun. 385, 198-203
84. Kumagai, T., Shimizu, T., and Takeda, K. (2006) Bone morphogenetic protein-2 suppresses invasiveness of TSU-Pr1 cells with the inhibition of MMP-9 secretion. Anticancer Res. 26, 293-298 (Pubitemid 43206089)
85. Pi, W., Guo, X., Su, L., and Xu, W. (2012) BMP-2 up-regulates PTEN expression and induces apoptosis of pulmonary artery smooth muscle cells under hypoxia. PLoS One 7, e35283
86. Huang, Y., Sook-Kim, M., and Ratovitski, E. (2008) Midkine promotes tetraspanin-integrin interaction and induces FAK-Stat1α pathway contributing to migration/invasiveness of human head and neck squamous cell carcinoma cells. Biochem. Biophys. Res. Commun. 377, 474-478